Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05649111

A Study of the Effect of Different Doses of Difluprednate Eye Drops on the Intraocular Pressure After Phacoemulsification

Conditions: Uveitis, Anterior

Sex: All

Ages: 40 Years – 80 Years

Phase: PHASE4

Enrollment: 20

Sponsor: Kafrelsheikh University

Location: Egypt

Summary

The study aims at detecting the minimum effective daily dose and duration of difluprednate that can be used to treat postoperative inflammation after phacoemulsification without increasing the intraocular pressure, and whether it can be safely given within the first 24 hours after the operation.

Eligibility Criteria

Inclusion Criteria:Age 40-80Grade 1 to 4 nuclear cataract LOCS IICumulative dissipated energy CDE 1 to 10Done by a single surgeon using the chopping techniqueExclusion Criteria:History of uveitisthe use of topical or systemic steroids on the last post-operative dayIntraoperative or postoperative complicationsIntraoperative iris manipulations or phaco traume

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05649111). StuddyBuddy aggregates publicly available trial information.